dance academy

Lorem ipsum dolor sit amet, consectetur at vero adipiscing elit, sed do eiusmod.

Our Provider

  /  Our Provider
Board Certified Internal Medicine/Nephrology

Anas Kayal, M.D.

Dr. Kayal joined San Diego Nephrology as a board-certified specialist in Nephrology and Internal Medicine. Dr. Kayal earned his doctorate from University of Damascus, Faculty of Medicine, Damascus, Syria in 2001, he completed his Internal Medicine residency at Michigan State University, East Lansing, MI from 2002 to 2005, took a fellowship in Nephrology at St. John Hospital and Medical Center, Detroit, MI from 2005 to 2007, and completed his Interventional Nephrology at U.C. Davis Medical Center, Sacramento, CA in 2011

Dr. Kayal specializes in diagnosing, treating, and preventing disease, with a special interest in kidney disease and high blood pressure. He works closely with adults to help manage chronic conditions and improve day-to-day life.

Dr Kaya shows a remarkable amount of compassion and concern for his patients. He feels strongly that his role is to act as an advocate for his patients along with providing continuity of care and forming lasting relationships with patients and their families.


Kayal Medical Group, Inc | Nephrology/hospitalis | 1/2020-present

Balboa Nephrology Medical group | North county San Diego, CA | 6/2014-5/2021

Northern Louisiana Medical Center | Ruston, LA | 5/2011- 5/2014

Wyoming Medical Center | Casper, WY | 10/2009-4/2010

Postdoctoral Training

Interventional Nephrology, U.C. Davis Medical Center | Sacramento CA | 7/2010-2/2011

Nephrology Fellowship, St. John Hospital and Medical Center | Detroit, MI | 7/2007 – 6/2009

Internal Medicine Residency, Michigan State University | East Lansing, MI | 7/2002 – 6/2005


Doctor of Medicine | University of Damascus, Faculty of Medicine Damascus, Syria | 2001

Hospital Appointments

Hospitalist (per-diem) | Temecula Valley Hospital | Temecula, CA | 01/2016 – present

Hospitalist | Aspirus Wausau Hospital | Wausau, WI | 7/2005 – 7/2007


8/2005 | American Board of Internal Medicine

11/2009 | American Board of Nephrology

6/2011 | American Society of Diagnostic and interventional Society


1. 12/2008 Long Term Outcome of Calcineurin Inhibitor Avoidance with Steroid Free Maintenance Environment.
2. Anas Kayal, Keshari Thakali, Catherine M. Rondelli, Ralph E. Watson, Arthur S. Rovner, Gregory D. Fink and Stephanie W. Watts. Medicine, Michigan State University, East Lansing, MI; Pharmacology and Toxicology, Michigan State University, East Lansing, MI; Molecular Physiology and Biophysics, University of Vermont, Burlington, VT. P-18: Myosin heavy chain B isoform is more predominant in rat veins than arteries. Am J Hypertens (2005) 18, 15A–15A; doi: 10.1016/j.amjhyper.2005.03.036

3. Rondelli Catherine M; Szasz Irina T; Kayal Anas; Thakali Keshari; Watson Ralph E; Rovner Arthur S; Eddinger Thomas J; Fink Gregory D; Watts Stephanie W
Preferential myosin heavy chain isoform B Expression may contribute to the faster velocity of contraction in veins versus arteries. Journal of vascular research 2007; 44(4): 264-72